122 related articles for article (PubMed ID: 12618898)
1. Human kallikrein 2 (hK2) mRNA in peripheral blood of patients with thyroid cancer: a novel molecular marker?
Roddiger SJ; Renneberg H; Martin T; Tunn UW; Zamboglou N; Kurek R
J Cancer Res Clin Oncol; 2003 Jan; 129(1):29-34. PubMed ID: 12618898
[TBL] [Abstract][Full Text] [Related]
2. Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy.
Shariat SF; Gottenger E; Nguyen C; Song W; Kattan MW; Andenoro J; Wheeler TM; Spencer DM; Slawin KM
Cancer Res; 2002 Oct; 62(20):5974-9. PubMed ID: 12384565
[TBL] [Abstract][Full Text] [Related]
3. Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein.
Slawin KM; Shariat SF; Nguyen C; Leventis AK; Song W; Kattan MW; Young CY; Tindall DJ; Wheeler TM
Cancer Res; 2000 Dec; 60(24):7142-8. PubMed ID: 11156423
[TBL] [Abstract][Full Text] [Related]
4. Detection of clinically significant, occult prostate cancer metastases in lymph nodes using a splice variant-specific rt-PCR assay for human glandular kallikrein.
Shariat SF; Kattan MW; Erdamar S; Nguyen C; Scardino PT; Spencer DM; Wheeler TM; Slawin KM
J Clin Oncol; 2003 Apr; 21(7):1223-31. PubMed ID: 12663708
[TBL] [Abstract][Full Text] [Related]
5. Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages.
Corey E; Arfman EW; Oswin MM; Melchior SW; Tindall DJ; Young CY; Ellis WJ; Vessella RL
Urology; 1997 Aug; 50(2):184-8. PubMed ID: 9255285
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous quantification of human glandular kallikrein 2 and prostate-specific antigen mRNAs in peripheral blood from prostate cancer patients.
Ylikoski A; Karp M; Pettersson K; Lilja H; Lövgren T
J Mol Diagn; 2001 Aug; 3(3):111-22. PubMed ID: 11486050
[TBL] [Abstract][Full Text] [Related]
7. Detection of prostate specific transcripts in the peripheral blood during brachytherapy predicts postoperative PSA kinetics.
Mabjeesh NJ; Amir S; Stenger A; Chen J; Matzkin H
Prostate; 2009 Aug; 69(11):1235-44. PubMed ID: 19434652
[TBL] [Abstract][Full Text] [Related]
8. Blood thyroglobulin and TSH receptor mRNA detection by RT-PCR in the follow-up of differentiated thyroid cancer patients.
Torosian L; Manrique G; Alvarez B; Lago G; Roca R; Belzarena C
Rev Esp Med Nucl; 2010; 29(3):109-13. PubMed ID: 20399540
[TBL] [Abstract][Full Text] [Related]
9. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance.
Stathopoulou A; Vlachonikolis I; Mavroudis D; Perraki M; Kouroussis Ch; Apostolaki S; Malamos N; Kakolyris S; Kotsakis A; Xenidis N; Reppa D; Georgoulias V
J Clin Oncol; 2002 Aug; 20(16):3404-12. PubMed ID: 12177100
[TBL] [Abstract][Full Text] [Related]
10. Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes.
Shariat SF; Roudier MP; Wilcox GE; Kattan MW; Scardino PT; Vessella RL; Erdamar S; Nguyen C; Wheeler TM; Slawin KM
Cancer Res; 2003 Aug; 63(15):4662-70. PubMed ID: 12907647
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of thyroid peroxidase mRNA in peripheral blood for early detection of thyroid papillary carcinoma.
Ishikawa T; Miwa M; Uchida K
Thyroid; 2006 May; 16(5):435-42. PubMed ID: 16756464
[TBL] [Abstract][Full Text] [Related]
12. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
Ringel MD; Balducci-Silano PL; Anderson JS; Spencer CA; Silverman J; Sparling YH; Francis GL; Burman KD; Wartofsky L; Ladenson PW; Levine MA; Tuttle RM
J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
[TBL] [Abstract][Full Text] [Related]
13. Blood presence of circulating oncofetal fibronectin mRNA, by RT-PCR, does not represent a useful specific marker for the management and follow-up of thyroid cancer patients.
Vendittelli F; Raffaelli M; Fadda G; Carelli-Alinovi C; Paolillo C; Bellantone R; Zuppi C; Capoluongo E
Clin Chem Lab Med; 2012 Jan; 50(4):715-20. PubMed ID: 22505562
[TBL] [Abstract][Full Text] [Related]
14. Molecular detection of thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease by RT-PCR.
Bojunga J; Röddiger S; Stanisch M; Kusterer K; Kurek R; Renneberg H; Adams S; Lindhorst E; Usadel KH; Schumm-Draeger PM
Br J Cancer; 2000 May; 82(10):1650-5. PubMed ID: 10817499
[TBL] [Abstract][Full Text] [Related]
15. Expression of prostate-specific antigen and human glandular kallikrein 2 in the thyroid gland.
Magklara A; Cheung CC; Asa SL; Diamandis EP
Clin Chim Acta; 2000 Oct; 300(1-2):171-80. PubMed ID: 10958873
[TBL] [Abstract][Full Text] [Related]
16. Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.
Okegawa T; Kinjo M; Nutahara K; Higashihara E
J Urol; 2004 Apr; 171(4):1461-6. PubMed ID: 15017198
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of quantitative measurement of thyroglobulin mRNA in the follow-up of differentiated thyroid cancer.
Denizot A; Delfino C; Dutour-Meyer A; Fina F; Ouafik L
Thyroid; 2003 Sep; 13(9):867-72. PubMed ID: 14588101
[TBL] [Abstract][Full Text] [Related]
18. Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.
Haese A; Vaisanen V; Lilja H; Kattan MW; Rittenhouse HG; Pettersson K; Chan DW; Huland H; Sokoll LJ; Partin AW
J Urol; 2005 Mar; 173(3):752-6. PubMed ID: 15711262
[TBL] [Abstract][Full Text] [Related]
19. Expression of cytokeratin 20 in thyroid carcinomas and peripheral blood detected by reverse transcription polymerase chain reaction.
Weber T; Lacroix J; Weitz J; Amnan K; Magener A; Hölting T; Klar E; Herfarth C; von Knebel Doeberitz M
Br J Cancer; 2000 Jan; 82(1):157-60. PubMed ID: 10638983
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer.
Milas M; Barbosa GF; Mitchell J; Berber E; Siperstein A; Gupta M
Ann Surg Oncol; 2009 Feb; 16(2):473-80. PubMed ID: 19015922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
